Tacrolimus ointment promotes repigmentation of vitiligo in children: A review of 57 cases

Nanette B. Silverberg, Peggy Lin, Lisa Travis, Jeanne Farley-Li, Anthony J. Mancini, Annette M. Wagner, Sarah L. Chamlin, Amy S. Paller

Research output: Contribution to journalArticlepeer-review

118 Scopus citations


Vitiligo is an autoimmune disorder characterized by loss of pigmentation. Phototherapy and application of topical corticosteroids are most commonly prescribed. However, these therapies are often not effective and use of corticosteroids on the face may lead to cutaneous atrophy, telangiectasia, and ocular complications. We sought to assess the efficacy of topical tacrolimus ointment in the treatment of pediatric vitiligo. A retrospective review was performed of 57 pediatric patients with vitiligo at two clinical sites. Patients were treated with tacrolimus ointment for at least 3 months. Clinical responses were documented during clinic visits, and by pretacrolimus and posttacrolimus photography. At least partial response was noted to tacrolimus ointment on the head and neck in 89%, and on the trunk and extremities in 63% of patients. Facial vitiligo of the segmental type showed the best response rate. Two patients initially experienced burning on application. Topical tacrolimus ointment is an effective alternative therapy for childhood vitiligo, particularly involving the head and neck.

Original languageEnglish (US)
Pages (from-to)760-766
Number of pages7
JournalJournal of the American Academy of Dermatology
Issue number5
StatePublished - Nov 2004

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'Tacrolimus ointment promotes repigmentation of vitiligo in children: A review of 57 cases'. Together they form a unique fingerprint.

Cite this